Regeneron Pharmaceuticals
REGN
REGN
1,061 hedge funds and large institutions have $54.7B invested in Regeneron Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 93 funds opening new positions, 375 increasing their positions, 415 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $64.1B → $54.7B (-$9.45B)
15% less first-time investments, than exits
New positions opened: 93 | Existing positions closed: 110
27% less call options, than puts
Call options by funds: $707M | Put options by funds: $974M
Holders
1,061
Holding in Top 10
22
Calls
$707M
Puts
$974M
Top Buyers
| 1 | +$529M | |
| 2 | +$464M | |
| 3 | +$197M | |
| 4 |
Morgan Stanley
New York
|
+$195M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$185M |
Top Sellers
| 1 | -$509M | |
| 2 | -$332M | |
| 3 | -$330M | |
| 4 |
Two Sigma Investments
New York
|
-$145M |
| 5 |
Two Sigma Advisers
New York
|
-$137M |